nta.org
  • About
    • About
    • Media
    • Catalyst Communities
    • Catalyst Partners
    • How To Engage
  • Opportunities
    • Advanced Communications
    • Advanced Materials
    • Aerospace & Defense
    • AI & Digital Transformation
    • Autonomy & Manufacturing
    • Biotech & Medical
    • Energy & Sustainability
    • Microelectronics
  • Events
    • Events
    • Webinars
  • News
    • ADVANCED COMMUNICATIONS
    • ADVANCED MATERIALS
    • AEROSPACE & DEFENSE
    • AI & DIGITAL TRANSFORMATION
    • AUTONOMY AND MANUFACTURING
    • BIOTECH & MEDICAL
    • ENERGY & SUSTAINABILITY
    • MICROELECTRONICS
  • Join NTA
HomeOPPORTUNITIESPoint-of-Care Detection of Prostate Specific Antigen

Point-of-Care Detection of Prostate Specific Antigen

October 6, 2023 Administrator OPPORTUNITIES 0

Due: November 14, 2023

The development of an accurate, inexpensive home test for Prostate Specific Antigen (PSA) is both an unmet need and an NCI priority for reducing cancer mortality by half within 25 years.

CLOSED
  • AEROSPACE AND DEFENSE
  • BIOTECH AND MEDICAL
  • CLOSED
  • MICROELECTRONICS
  • OPPORTUNITIES
  • Contact Us
  • Privacy Policy & Terms of Use

NTA is operated by the 501c(3) non-profit Advanced Technology International (ATI). National Technology Alliance (NTA) © 2024 - All rights reserved.